fbpx

< Back to Thought Leadership

On-Demand Webinar: The Future of the 340B Program

Over the past year, there have been many changes within the 340B Program.

Join Jason Prokopik from Blue & Co., LLC and Wes Butler from Barnett Benvenuti & Butler on Tuesday, February 9 from noon to 1 p.m. EST as they discuss how the recent political changes could impact the 340B Program and what it could mean for your organization.

Agenda:

  • Political changes and impact on 340B
  • 340B Program Updates

Speakers

Jason Prokopik is a Manager with Blue & Co., LLC on the Indianapolis Reimbursement team specializing in fiscal and operational management related to pharmacy.

Wes Butler is a health care attorney based in Lexington, Kentucky. His law practice focuses on advising health care providers on regulatory matters that implicate safety, quality, and reimbursement.

Download the Webinar Resources Below:


Share this article

MGCRB Reclassification Withdrawal: What Hospitals Need to Know for FY 2027

For hospitals that would like to withdraw an approved Geographic Reclassification, the publishing of the FY 2027 proposed rule starts the 45-day window for withdrawing approved Medicare Geographic Classification Review […]

Learn More

Beyond Compliance: The Strategic Value of Independent External 340B Audits

The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients.  However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]

Learn More
not-for-profit data management

From Data to Decisions: Strengthening Not-For-Profit Finance in an AI-Driven World

By Joell Grisel, CPA, Director at Blue & Co. Financial technology keeps evolving at a pace that is hard for many not-for-profits to keep up with. At Blue & Co., […]

Learn More